What happens next in GLP-1 — and when.

What changed › 2026-09-25

A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects

Detected 2026-09-25 in the trials record for semaglutide, by comparing that day’s fetch against the previous one.

A completion date is the sponsor's estimate of when the main result will be in hand. ClinicalTrials.gov overwrites the old date when it moves, keeping no public history, so the previous value below exists nowhere else.

What changed

ChangeFieldValue
results date movedprimary_completion_date2026-07 → 2026-03-07

What the record says now

Status
Completed
Phase
P3
Participants
408
Primary completion
2026-03-07
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

See semaglutide · NCT06738979 · the source record.

The previous value above is not recoverable from the source. Both ClinicalTrials.gov and the FDA revise records in place, keeping no public history, which is why this site keeps its own.

@glp1briefing